Lanzhou Foci Pharmaceutical Co., Ltd.

4 records, newest first. Each line links to the FDA page it came from.

Questions about Lanzhou Foci Pharmaceutical Co., Ltd.

Is Lanzhou Foci Pharmaceutical Co., Ltd. on an FDA import alert?

Yes. As of October 26, 2026, Lanzhou Foci Pharmaceutical Co., Ltd. is on the red list of FDA Import Alert 54-14, “Supplements from firms not meeting supplement GMP”, for bao he teapills (bao he wan); xiang sha yang wei wan (digestive aid); xiao chai hu tang wan (liver smooth); bao he wan (strengthen digestion); huo xiang zheng qi wan (strengthen dampness); xiang sha liu jun wan (digestion ease); clear mountain air teapills (ding chuan wan); xiang sha yang wei wan;…; FDA published the listing on July 14, 2025.

Has FDA refused shipments from Lanzhou Foci Pharmaceutical Co., Ltd.?

No FDA import refusals for Lanzhou Foci Pharmaceutical Co., Ltd. appear in FDA's refusal data since October 2016, as of October 26, 2026.

When was Lanzhou Foci Pharmaceutical Co., Ltd. last inspected by FDA?

FDA's most recent inspection of Lanzhou Foci Pharmaceutical Co., Ltd. with a final classification is dated March 20, 2025 and was classified OAI (Official Action Indicated).

What is Lanzhou Foci Pharmaceutical Co., Ltd.'s FEI number?

Lanzhou Foci Pharmaceutical Co., Ltd.'s FDA Establishment Identifier (FEI) is 3004252872.

Can shipments from Lanzhou Foci Pharmaceutical Co., Ltd. still enter the U.S.?

Shipments of bao he teapills (bao he wan); xiang sha yang wei wan (digestive aid); xiao chai hu tang wan (liver smooth); bao he wan (strengthen digestion); huo xiang zheng qi wan (strengthen dampness); xiang sha liu jun wan (digestion ease); clear mountain air teapills (ding chuan wan); xiang sha yang wei wan;… from Lanzhou Foci Pharmaceutical Co., Ltd. can be detained without physical examination under Import Alert 54-14; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).